Search

everythinglearnresearchcommunity

for

Search:↓

L-cysteine slows down the breaking of bonds in hair due to electrostatic interactions.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Ethosomal carriers effectively deliver hair loss drug into skin.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Juglone from walnut extracts may help repair damaged hair.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

New method makes important drug ingredients more easily without needing extra purification steps.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.